Wolverine stack (BPC-157 + TB-500 5 mg + 5 mg)

Description

This dual pathway stack pairs BPC-157 (tissue signaling) with TB-500 (actin-binding fragment of thymosin β4)(Wolverine stack) for models exploring tendon, ligament, and soft-tissue recovery along with angiogenesis and cell migration.

A synergistic blend of BPC-157 (Body Protecting Compound) and TB-500 (Thymosin Beta-4 fragment) for enhanced tissue repair and recovery.
Benefits:
• Speeds healing of tendons, ligaments, muscles & gut
• Reduces inflammation & pain
• Improves flexibility and joint health
• Ideal for athletes or post-injury recovery

Why Cellugenix: Clean, consistent presentation for multi-compound protocols; clear traceability.

Key Benefits (Research Context):

• Combines local tissue signaling with systemic repair pathways

• Useful in post-strain/overuse model frameworks

• Streamlines blend logistics for study arms

Specifications:

• Strength: 5 mg + 5 mg per vial •

Appearance: Lyophilized powder

• Purity: ≥99%

• Storage: 2–8 °C

 For Research Purposes Only – Not for Human Use